연구보고서 RSS 설명 www.khidi.or.kr ko COPYRIGHT 2015 KOREA HEALTH INDUSTRY DEVELOPMENT INSTITUTE. ALL RIGHTS RESERVED. www.khidi.or.kr <![CDATA[신흥 3개국(러시아, 브라질, 인도네시아) 진단검사 전문기관 진출 환경조사]]> Ⅰ. 서 론 ·····························································································1
제1장 조사 개요 ······························································································3
제1절 조사 배경 및 필요성 ·····························································································5
1. 조사의 배경 ··············································································································5
2. 조사의 필요성 ··········································································································8
제2절 조사 목적 및 한계 ·································································································9
1. 조사의 목적 ··············································································································9
2. 조사대상 국가 ········································································································10
3. 조사의 한계 ···········································································································14
제2장 감염병 및 진단검사 서비스 시장의 이해 ··········································15
제1절 감염병의 이해 ······································································································17
1. 감염병의 정의 ········································································································17
2. 감염병의 단계 및 진단 방법 ················································································21
제2절 진단검사 서비스 시장의 이해 ·············································································23
1. 진단검사의 이해 ····································································································23
2. 진단검사 시장의 규모 ···························································································27
3. 진단검사 서비스 시장의 구분 및 전망 ································································31
4. 국내 진단검사 서비스 시장 현황 및 전망 ···························································46
5. 진단검사 서비스 기관의 수요 정보 ······································································53
Ⅱ. 러시아 진단검사 전문기관 진출 환경조사 ································55
제1장 일반 환경 ···························································································57
제1절 국가 일반현황 ······································································································59
1. 국가 개황 ···············································································································59
- ii -
2. 경제 현황 ···············································································································61
3. 정치 환경 ···············································································································65
제2절 보건의료 환경 ······································································································66
1. 인구 통계적 환경 ··································································································66
2. 일반 질환 현황 ······································································································69
3. 감염병 현황 ···········································································································75
제2장 보건의료 자원 및 재원 ······································································83
제1절 보건의료자원 ········································································································85
1. 보건의료 정책 ········································································································85
2. 보건의료인력 ··········································································································87
3. 보건의료시설 현황 ·································································································90
제2절 보건의료 재원 ······································································································96
1. 보건의료 비용 ········································································································96
2. 의료보험제도 ··········································································································98
제3장 감염병 대응 체계 ·············································································101
제1절 감염병 관리체계 ································································································103
1. 감염병 관련 법 개관 ···························································································103
2. 감염병 관리 자원 ································································································105
제2절 공중보건 위기관리 대응 사례 ···········································································107
1. 코로나19 대응 ·····································································································107
2. 결핵 ·····················································································································112
3. 성적으로 감염되는 질환(STIs) ···········································································115
제4장 러시아 진단검사 서비스 시장의 이해 ·············································117
제1절 러시아 진단검사 서비스 시장의 이해 ······························································119
1. 진단검사 서비스 시장의 구분 ·············································································119
2. 진단검사 서비스 시장의 구성 ·············································································121
3. 진단검사기관 관련 의료인력 ···············································································130
제2절 러시아 진단검사 서비스 시장에 대한 전망 ·····················································134
1. 진단검사 서비스 시장의 성장요인 ······································································134
- iii -
2. 진단검사 건수 기준 시장 전망 ···········································································135
3. 진단검사 수익 기준 시장 전망 ···········································································137
4. 진단검사 서비스 구분별 전망 ·············································································140
제3절 진단검사 전문기관 사례 ····················································································148
1. 진단검사 전문기관 현황 ······················································································148
2. 진단검사 전문기관 현황 분석 ·············································································151
제4절 진단검사 서비스 관련 수가 ··············································································173
제5장 진단검사 전문기관 진출환경 ···························································183
제1절 외국인투자 제도 ································································································185
1. 외국인투자에 관한 법⋅규정 및 기본원칙 ·························································185
2. 외국투자법인 설립 및 청산 ················································································188
제2절 진단검사 전문기관 진출환경 ·············································································194
1. 진단검사 전문기관 설립 ······················································································194
2. 진단검사기관의 설립 절차 및 요건 ····································································195
3. 진단검사 전문기관의 운영 관련 사항 ································································200
4. 외국 진단검사 전문인력 자격 인정 및 활동 허용범위 ·····································202
제3절 의료기기 등록 절차 ···························································································207
제4절 원격의료 시장현황 ·····························································································213
Ⅲ. 브라질 진단검사 전문기관 진출 환경조사 ······························217
제1장 일반현황 ···························································································219
제1절 국가 일반현황 ····································································································221
1. 국가 개황 ·············································································································221
2. 경제 현황 ·············································································································222
3. 정치 환경 ·············································································································228
제2절 보건의료 환경 ····································································································229
1. 인구 통계적 환경 ································································································229
2. 일반 질환 현황 ····································································································232
3. 감염병 현황 ·········································································································235
- iv -
제2장 보건의료 자원 및 재원 ····································································251
제1절 브라질 보건 시스템 ···························································································253
제2절 보건의료 자원 ····································································································258
1. 보건의료 인력 ······································································································260
2. 보건의료시설 현황 ·······························································································263
제3절 보건의료 재원 ····································································································268
1. 보건의료 비용 ······································································································268
2. 의료보험제도 ········································································································271
제3장 감염성 대응 체계 ·············································································277
제1절 감염병 관리체계 ································································································279
제2절 공중보건 위기관리 대응 사례 ···········································································285
1. 코로나19 대응 ·····································································································285
2. 결핵 ·····················································································································292
3. 성적으로 감염되는 질환(STIs) ···········································································295
제4장 브라질 진단검사 서비스 시장의 이해 ·············································297
제1절 브라질 의료시장의 개관 ····················································································299
1. 브라질 진단검사 서비스 시장의 이해 ································································299
2. 진단검사 서비스 시장의 규모 ·············································································307
제2절 진단검사 서비스 시장 전망 ··············································································311
1. 진단검사 서비스 시장 전반 ················································································311
2. 진단검사 서비스 구분별 전망 ·············································································314
제3절 진단검사 전문기관 사례 ····················································································324
1. 주요 기관 현황 및 특징 ·····················································································324
2. 주요 기관 ·············································································································326
제4절 진단검사 서비스 관련 수가 ··············································································345
1. 특정 서비스에 대한 지불 ····················································································345
2. 수가 사례 ·············································································································347
- v -
제5장 진단검사 전문기관 진출환경 ···························································351
제1절 외국인투자 제도 ································································································353
1. 외국인투자에 관한 법⋅규정 및 기본원칙 ·························································353
2. 외국 투자법인 설립 및 청산 ··············································································356
제2절 진단검사 전문기관 진출환경 ·············································································362
1. 진단검사 전문기관 설립 ······················································································362
2. 진단검사 전문기관의 운영 관련 사항 ································································370
3. 외국 진단검사 전문인력 자격 인정 및 활동 허용범위 ·····································379
제3절 의료기기 등록 절차 ···························································································380
Ⅳ. 인도네시아 진단검사 전문기관 진출 환경조사 ·······················383
제1장 일반 환경 ·························································································385
제1절 국가 일반현황 ····································································································387
1. 국가 개황 ·············································································································387
2. 경제 현황 ·············································································································389
3. 정치 환경 ·············································································································394
제2절 보건의료 환경 ····································································································395
1. 인구 통계적 환경 ································································································395
2. 일반 질환 현황 ····································································································398
3. 감염병 현황 ·········································································································401
제2장 보건의료 자원 및 재원 ····································································409
제1절 보건의료 자원 ····································································································411
1. 보건의료 인력 ······································································································411
2. 보건의료 시설 ······································································································422
제2절 보건의료 재원 ····································································································432
1. 보건의료 비용 ······································································································432
2. 의료보험제도 ········································································································435
- vi -
제3장 감염병 대응 체계 ·············································································439
제1절 감염병 관리체계 ································································································441
제2절 공중보건 위기관리 대응 사례 ···········································································444
1. 코로나19 대응 ·····································································································444
2. 성적으로 감염되는 질환(STIs) ···········································································448
제4장 인도네시아 진단검사 서비스 시장의 이해 ······································451
제1절 인도네시아 진단검사 서비스 시장 구조 ···························································453
1. 진단검사기관의 정의 및 구성 ·············································································453
2. 인도네시아 진단검사 서비스 시장규모 ·······························································458
3. 민간 진단검사기관의 가치사슬 ···········································································462
제2절 인도네시아 진단검사 서비스 시장에 대한 전망 ··············································467
1. 진단검사 서비스 시장 전망 ················································································467
2. 진단검사 서비스 시장 구분별 전망 ····································································470
제3절 진단검사 전문기관 사례 ····················································································478
1. Prodia의 사업전략 ······························································································479
2. 기타 진단검사 전문기관 ······················································································490
제4절 진단검사 서비스 관련 수가 ··············································································492
제5장 진단검사 전문기관 진출환경 ···························································499
제1절 외국인투자 제도 ································································································501
1. 외국인투자에 관한 법⋅규정 및 기본원칙 ·························································501
2. 외국 투자법인 설립 및 청산 ··············································································505
3. 외환제도 및 과실송금 ·························································································509
제2절 진단검사 전문기관 진출환경 ·············································································511
1. 진단검사 전문기관 설립 ······················································································511
2. 진단검사기관의 운영 관련 사항 ·········································································519
3. 외국 진단검사 전문인력 자격 인정 및 활동 허용범위 ·····································522
제3절 의료기기 등록 절차 ···························································································524
- vii -
제4절 원격의료 ·············································································································528
1. 인도네시아의 원격의료 ························································································528
2. 원격의료 관련 회사 사례 ····················································································532
Ⅴ. 결 론 ························································································535
제1장 진출환경 비교 ··················································································537
제1절 대상 국가의 보건 환경 ·····················································································539
1. 인구통계적 특성 ··································································································539
2. 질병구조 ···············································································································541
3. 감염병 대응 능력 ································································································542
제2절 대상 국가 진출환경 ···························································································545
1. 수요 접근성 ·········································································································545
2. 사업의 수행 용이성 ·····························································································549
3. 진단검사 관련 인프라 ·························································································553
제2장 진단검사 전문기관 진출 전략 ·························································559
제1절 진단검사 서비스 시장 분석 요약 ·····································································561
1. 진단검사 서비스 시장규모 및 성장률 ································································561
2. 진단검사 전문기관 운영방식의 이해 ··································································568
3. 진단검사 서비스 지불자 비교 ·············································································571
4. 운영방식 비교 ······································································································574
제2절 SWOT분석 및 진출전략 ···················································································577
1. 진단검사 서비스 시장 성장의 결정요인 ·····························································577
2. SWOT 분석 ········································································································581
3. 진출 전략 ·············································································································587

]]>
<![CDATA[2020년 4분기 보건산업 고용동향]]> 2020년 4분기 보건산업 고용동향 보고서입니다.

]]>
<![CDATA[2020년 화장품산업 분석 보고서]]> 2020년 화장품산업 분석 보고서

]]>
<![CDATA[만성질환자 건강관리앱 활용 모델 개발 및 실증사업]]> 한국보건산업진흥원에서 발간한 "만성질환자 건강관리앱 활용 모델 개발 및 실증사업" 연구보고서 입니다.


<차례>


요약문 / 1


제1장 연구개요 / 5

1. 연구 필요성 및 목적 ··················································································· 5

2. 국내외 관련 정책 및 제도 ········································································ 10

3. 연구 수행 체계 ························································································· 24

4. 연구내용 및 방법 ···················································································· 25


제2장 만성질환 건강관리 어플리케이션 활용 모델 개발 / 31

1. 건강관리 모바일 어플리케이션 활용 중재연구에 대한 문헌 고찰 ·············· 31

2. 국내 주요 건강관리 모바일 어플리케이션 ················································· 40

3. 일차의료기관 방문 만성질환자 대상 건강관리 어플리케이션 활용 모델 ···· 44


제3장 만성질환 건강관리 어플리케이션 효과 분석 / 50

1. 사업 운영 및 진행 현황 ············································································ 50

2. 사업 효과 분석 ························································································· 58


제4장 Focus􀀁 Group􀀁 Interview􀀁 및 전문가 자문 회의 / 76


제5장 만성질환 건강관리 어플리케이션 활용 방안 및 정책제안 / 84

1. 만성질환 건강관리 어플리케이션 활용 방안 ············································ 84

2. 만성질환 건강관리 어플리케이션 활용 정책 제안 ······································ 89


참고문헌 / 94

부록 / 99

1. 연구 동의서 ···························································································· 101

2. 참여 의원 List ························································································ 103

3. 설문지 ····································································································· 104


]]>
<![CDATA[2019 외국인환자 유치실적 통계분석 보고서]]> 한국보건산업진흥원에서 발간한 "2019 외국인환자 유치실적 통계분석 보고서" 입니다.


<목차>

part1 2019 외국인환자 유치실적 조사개요 / 1


part2 2019 외국인환자 유치실적 주요 통계 / 5


part3 주요 요인별 통계 / 27

가. 국가별 유치현황 ··································································································· 28

나. 지역별 유치현황 ··································································································· 65

다. 의료기관 유형별 유치현황 ················································································· 124


부 록 / 143

]]>
<![CDATA[디지털시대 의료서비스 혁신을 위한 스마트병원 육성 방안 연구]]> 한국보건산업진흥원에서 발간한 "디지털시대 의료서비스 혁신을 위한 스마트병원 육성 방안 연구"보고서 입니다.


<차 례>

제1장 연구개요 / 1

1. 연구배경 및 목적·································································································· 1

2. 연구내용 및 방법 ································································································· 2


제2장 스마트병원의 등장배경 / 4

1. 국내외 보건의료 환경의 변화················································································ 4

2. 의료서비스 패러다임의 변화 요구······································································· 13


제3장 스마트병원의 개념 및 기대효과 / 16

1. 스마트병원의 개념······························································································· 16

2. 디지털 병원과의 차이점 ····················································································· 20

3. 스마트 헬스케어에서의 스마트병원의 역할·························································· 23

4. 스마트병원의 개념 정립 ····················································································· 25

5. 스마트병원의 기대효과························································································ 29


제4장 주요국의 스마트병원 정책 추진 동향 / 32

1. 싱가포르·············································································································· 32

2. 중국····················································································································· 34

3. 일본····················································································································· 39

4. 호주····················································································································· 40

5. 영국····················································································································· 41

6. 덴마크················································································································· 43

7. 한국 ··················································································································· 44

8. 시사점 ················································································································ 45

ii


제 5장 국내 의료기관들의 스마트화 움직임 / 47

1. 주요 의료기관들의 스마트병원 추진 전략 ························································ 47

2. 디지털 솔루션 도입 실패 사례 ·········································································· 58

3. 시사점 ················································································································ 64


제6장 의료기관의 당면 문제 / 65

1. 의료기관의 당면 문제 ························································································ 65

2. 도입 가능한 스마트화 요소················································································· 99

3. 의료기관들의 스마트화 저해요인······································································· 118


제7장 스마트병원 관련 기술 동향 및 국내 기업 현황 / 127

1. 글로벌 스마트병원 시장 현황············································································ 127

2. 스마트병원 관련 주요 기술의 서비스 적용 사례 ············································· 129

3. 스마트화 요소 관련 국내기업 현황 및 문제점·················································· 135


제8장 스마트병원 육성 방안 / 149

1. 스마트병원 육성을 위한 고려사항····································································· 149

2. 스마트병원 육성 방안 ······················································································ 158


제9장 요약 및 정책제언 / 171


참고문헌 / 177

]]>
<![CDATA[2020년 외국인환자유치 온라인 의료광고 가이드라인]]> 한국보건산업진흥원에서 발간한 "외국인환자유치 온라인 의료광고 가이드라인" 입니다.


이 가이드라인은

외국인환자를 유치하려는 의료기관 및 유치업자가

온라인 의료광고를 할 경우, 준수해야 할 사항을

주요 위반유형과 사례 중심으로 안내하고 있습니다.


이 가이드라인의 부당한 표시・광고 유형은

외국인환자유치 온라인 의료광고에서 발생하기 쉬운 주요 위반유형을

예시한 것으로, 이 가이드라인에 열거되지 아니한 행위라고 해서

부당한 표시・광고에 해당되지 않는 것은 아닙니다.


외국인환자유치 온라인 의료광고 내용에 관한 사항은

보건복지부, 한국보건산업진흥원,

한국인터넷광고재단에 문의하시기 바랍니다.


또한, 외국인환자 유치기관의 등록 등에 관한 사항은

관할 시・도로 문의하시기 바랍니다.


<목차>

I. 가이드라인 개요 - 1


II. 주요 위반유형 및 사례 - 7

1. 주요 위반유형 - 9

2. 주요 위반사례 - 11


부록 - 33


]]>
<![CDATA[국내 보건의료 연구개발 정부투자 현황분석]]> 한국보건산업진흥원에서 발간한 "국내 보건의료 연구개발 정부투자 현황분석" 보고서 입니다.


<목차>

1. 개요 5

1-1. 보건의료기술의 정의 및 범위 5

1-2. 보건의료기술표준분류체계 특성 및 구성 7


2. 분석범위 및 방법 9


3. 보건의료 R&D 정부 투자 현황 13


4. 보건의료기술표준분류체계 기준 투자현황 분석 16

4-1. 질환별 16

4-2. 연구행위 및 산출물별 18

4-3. 의약품 제품개발 단계별 20


5. 사회경제적 지표통계와의 비교 분석 22

5-1. 사회경제적 지표통계와 비교 분석 의미 22

5-2. 진료비 통계, 질병부담(GBD)과 비교분석 23

5-3. 사망원인질환에 대한 투자분석 28


[부록] 39

]]>
<![CDATA[글로벌 인공지능 병리 ·영상의료기기 산업 ·제도 동향]]> 한국보건산업진흥원에서 발간한 "글로벌 인공지능 병리 ·영상의료기기 산업 ·제도 동향" 보고서 입니다.


<차례>


제1장 서론 / 1

1. 연구 배경 및 목적 ································································································· 1

2. 연구의 범위 및 방법 ····························································································· 3

3. 기대효과 및 활용방안 ···························································································· 4


제2장 글로벌 산업 동향 / 5

1. 산업의 정의와 범위 ······························································································· 5

2. 촉진·억제·기회요인 ································································································ 7

3. 주요 산업 동향 ···································································································· 14


제3장 주요 선진국 제도 동향 및 비즈니스 모델 / 20

1. 국가별 의료기기 규제 동향 ················································································· 20

2. 보험 적용 동향 ···································································································· 29

3. 비즈니스 모델 ······································································································ 33


제4장 중국 산업·제도 동향 / 35

1. 산업현황 ·············································································································· 35

2. 정책 및 제도 ······································································································· 41


5장 글로벌 업체 동향 / 49

1. 글로벌 업체 동향 ································································································ 49

2. 중국 업체 동향 ···································································································· 53


제6장 결 론 / 60


]]>
<![CDATA[재난적 감염병 재유행에 대비한 보건산업 법제기반 강화 연구]]> 한국보건산업진흥원에서 발간한 "재난적 감염병 재유행에 대비한 보건산업 법제기반 강화 연구" 보고서 입니다.


<목차>


I. 서론 1

1. 연구의 배경 및 목적 1

2. 연구의 방법 5


II. 재난적 감염질환의 백신개발 등에 관한 특별법 제정 방안 6

1. 들어가며 6

2. 감염병 대응을 위한 현행 제도 고찰 8

3. 신종 감염병 발생 시 대응 동향 23

4. 코로나코로나19 대응 외국 사례 35

5. 특별법 제정의 필요성필요성-신종 감염병에 대응하기 위한 현행 법체계의 한계와 문제점 40

6. 특별법 입법제안 46


III. 보건의료 R&D 거버넌스 재정립 및 보건산업 육성 91

1. 보건의료 R&D 거버넌스 개요 91

2. 보건의료 R&D 거버넌스의 문제점 및 재정립 필요성 108

3. 보건의료 R&D 거버넌스 기구의 개편 방안방안(진흥법 제제6조 관련관련) 117

4. 보건산업 육성 법제의 개선방안 186

5. 보건의료기술 진흥법 개정안 221

6. [보론보론] 해외 보건의료 R&D 거버넌스 분석 235


IV. 참고문헌 256

[별첨별첨] 특별법특별법(가칭 「재난적 감염질환 백신개발 등에 관한 특별법」 초안 1





]]>